Search - tctmd.com

Displaying 461 - 480 of 1989

Sort: Relevancy | Date

News Daily News

“阴性”动脉粥样硬化成像结果使 10 年心血管疾病风险下降：MESA 分析

Michael O'Riordan

January 28, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Daily News

The Case for Reviving PCI Readmission Metrics: A Holistic Approach Could Improve Both Quality, Value

Yael L. Maxwell

January 27, 2016

News Daily News

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Michael O'Riordan

January 26, 2016

News Daily News

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

Yael L. Maxwell

January 25, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Daily News

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

Yael L. Maxwell

January 25, 2016

News Daily News

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Todd Neale

January 25, 2016

News Daily News

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

Yael L. Maxwell

January 25, 2016

News Daily News

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Caitlin E. Cox

January 25, 2016

News Industry News

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

January 24, 2016

News Daily News

Low Serum Magnesium Tied to Cardiovascular Mortality, but Mechanisms Murky

Todd Neale

January 24, 2016

News Daily News

Meta Análisis: La Revascularización Completa Reduce la Mortalidad, los IM y las Nuevas Intervenciones en la EAC Multivaso

Michael O'Riordan

January 21, 2016

News Daily News

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-Analysis

Michael O'Riordan

January 21, 2016

News Industry News

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

January 21, 2016

News Daily News

Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs

Todd Neale

January 20, 2016

News Daily News

PCI para el Manejo del Shock Cardiogénico: La Mortalidad ha Aumentado Pareja al Riesgo de los Pacientes

Yael L. Maxwell

January 20, 2016

News Daily News

OCT Reveals Potential Causes of Very Late Stent Thrombosis

Caitlin E. Cox

January 19, 2016

News Daily News

Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure

Michael O'Riordan

January 19, 2016

News Daily News

Cardiologists Stand Out for Their Ties to Industry in US Government Database

Caitlin E. Cox

January 19, 2016

Advertisement

“阴性”动脉粥样硬化成像结果使 10 年心血管疾病风险下降：MESA 分析

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

The Case for Reviving PCI Readmission Metrics: A Holistic Approach Could Improve Both Quality, Value

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

Low Serum Magnesium Tied to Cardiovascular Mortality, but Mechanisms Murky

Meta Análisis: La Revascularización Completa Reduce la Mortalidad, los IM y las Nuevas Intervenciones en la EAC Multivaso

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-Analysis

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs

PCI para el Manejo del Shock Cardiogénico: La Mortalidad ha Aumentado Pareja al Riesgo de los Pacientes

OCT Reveals Potential Causes of Very Late Stent Thrombosis

Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure

Cardiologists Stand Out for Their Ties to Industry in US Government Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content